iterum therapeutics logo

Iterum Therapeutics

Iterum Therapeutics a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ITRM” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.iterumtx.com
Founded2015
Disease Focus
Development StageClinical
STOCK CODENASDAQ: ITRM
Address
200 S Wacker DriveSuite 650, IL 60606
Chicago
United States
Email
Contact Number
+1 312 778 6070

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/iterum-therapeutics” connections=”true” suffix=””]